Central Drugs Standard Control Organisation (CDSCO)
-
Thermo Fisher Scientific launches real-time PCR kits
The company has received licensing rights from Central Drugs Standard Control Organisation (CDSCO) and will be manufactured in India in…
Read More » -
CDSCO, State Drugs Control Administration commence joint inspection of Drug Manufacturing Units
The joint inspections are being conducted all over the country as per the standard operating procedures Under directions of Union…
Read More » -
Boehringer Ingelheim’s Jardiance bags CDSCO approval
The drug is the first treatment for heart failure with preserved ejection fraction (HFpEF) in India Boehringer Ingelheim has received…
Read More » -
Bharat Biotech awaits regulatory approvals to launch Covaxin for children
Central Drug Authority has recommended granting emergency use authorisation to Bharat Biotech’s Covaxin for children in the 2 to 18…
Read More » -
DST-funded start-up’s ELISA test breakthrough in COVID-19 treatment
The novelty of the technology is based on the measurement of electrochemical redox activity of IgM and IgG antibodies specific…
Read More » -
Natco Pharma seeks CDSCO approval for Molnupiravir capsules
The drug can be used for the treatment of corona virus Natco Pharma said it applied to the Central Drugs…
Read More » -
J&J seeks permission for phase-3 trial of COVID vaccine in India
The company also seeks regulator’s permission to import licence Multinational pharma giant Johnson & Johnson has applied to India’s drug…
Read More » -
India approves Oxford-AstraZeneca covid vaccine
The government and the SII are yet to sign an agreement on the purchase of the vaccine The Central Drugs…
Read More » -
Bharat Biotech’s Covaxin gets DCGI nod for phase 3 clinical trial
The vaccine ‘Covaxin’ is being indigenously developed by the Bharat Biotech in collaboration with the Indian Council of Medical Research…
Read More »